Complete your online assessment
Start with a short questionnaire about your health history and your goals. You can complete it from any device in Hawaii, at whatever hour suits you, with no office to travel to.
Bodi Envi connects adults in Hawaii with licensed providers who can prescribe personalized compounded tirzepatide when it is the right fit. The assessment, the review and the follow up all happen online, and the medication arrives by delivery.
How it works
Three steps, all online, from the first question to the delivery at your door.
Start with a short questionnaire about your health history and your goals. You can complete it from any device in Hawaii, at whatever hour suits you, with no office to travel to.
A licensed provider with Wasef Health, PC, the clinical organization for applicable Bodi Envi programs, reads your answers and decides whether personalized compounded tirzepatide is a safe and appropriate option for you.
If prescribed, VialsRx, Bodi Envi's current pharmacy partner for GLP-1 prescriptions, dispenses your medication and ships it to your Hawaii address.
Please note: a licensed provider determines whether treatment is appropriate. Treatment is not guaranteed. If a patient is not qualified, a refund will be issued.
Tirzepatide is a dual GIP and GLP-1 receptor agonist. Where semaglutide works on one receptor, tirzepatide engages two, each tied to a hormone involved in fullness and blood sugar control. For Hawaii residents, it is the medication behind Bodi Envi's Personalized Compounded Tirzepatide Weight-Management Programs.
The compounded form is prepared by a licensed compounding pharmacy for one named patient, on the strength of that patient's prescription. Dosing follows a plan the licensed provider set: a weekly injection, beginning at the dose the provider chooses and changing only when the provider decides it should.
Compounded medications sit outside FDA approval. Personalized Compounded Tirzepatide is not FDA-approved, is not equivalent to Mounjaro® and Zepbound®, and is not reviewed by the FDA for safety, effectiveness or quality before it is marketed. That is why each prescription rests on a licensed provider's individual judgement. Brand names are trademarks of their respective owners. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
Pricing does not change by location, so Hawaii residents see the same four plans as the rest of the country. Pay month to month or prepay a longer term for a lower monthly equivalent. The dose your provider sets does not change what you pay.
Billed monthly
$657 paid once
$1,230 paid once
$2,100 paid once
For applicable programs, pricing does not increase based solely on dosage strength. Medication is included only when a licensed healthcare provider determines treatment is medically appropriate and issues a prescription. Current pricing and plan details are on the Plans page.
The program reaches every part of Hawaii. From Honolulu, Pearl City, Hilo, Kailua, Waipahu and Kaneohe to rural counties, the steps are identical: an online health assessment, a licensed provider's decision, and delivery from the pharmacy partner to a valid Hawaii address.
Pharmacies that dispense medication to Hawaii patients are licensed and inspected by the Hawaii Board of Pharmacy. Compounded medications are prepared by a licensed compounding pharmacy under a patient specific prescription. Bodi Envi is not a medical practice, pharmacy or medication manufacturer, and does not compound medications itself. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards. Hawaii Board of Pharmacy.
For people in Hawaii, telehealth means the assessment fits around your day instead of the other way round. From Kaneohe to Honolulu, patients share their health history online, hear back from a licensed provider, and stay in touch with the care team by secure message. If treatment with personalized compounded tirzepatide is appropriate, the pharmacy partner delivers it to your door in Hawaii. There is no Hawaii office because none is needed.
Straight answers about eligibility, pricing and how the program works where you live.
Yes, through telehealth. Eligible adults in Hawaii are evaluated online by licensed providers, and where personalized compounded tirzepatide is prescribed the pharmacy partner dispenses it and ships it to your Hawaii address. Compounded medications are not FDA-approved and treatment is never guaranteed.
Hawaii patients pay the published national price: $229 a month on monthly billing, dropping to $219 on the 3-month term, $205 on the 6-month term and $175 a month on the 12-month term. Pricing does not increase based solely on dosage strength, and the /pricing page is the place to check the latest numbers.
You do not. The whole evaluation is online: an assessment you complete from home, reviewed by a licensed provider with Wasef Health, PC, who decides whether personalized compounded tirzepatide is appropriate. In most states the tailored treatment plan comes to you through online questionnaire and secure chat.
Licensed healthcare providers independently evaluate each Hawaii patient and decide whether treatment is medically appropriate. Wasef Health, PC is the clinical provider organization for applicable Bodi Envi programs, with Michael Wasef, MD as Medical Director.
The current pharmacy partner for GLP-1 prescriptions is VialsRx. Once a licensed provider prescribes personalized compounded tirzepatide, the pharmacy partner dispenses it and handles delivery. Availability may vary by program and patient location.
No, and the difference matters. Personalized Compounded Tirzepatide is prepared by a compounding pharmacy for an individual patient and is not FDA-approved, while Mounjaro® and Zepbound® are FDA-approved products. Compounded medications are not equivalent to them. Brand names are trademarks of their respective owners. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
It is. LegitScript certification is shown in the footer of every Bodi Envi page, and the badge links to LegitScript's own record so you can check it for yourself.
Yes. Both personalized compounded semaglutide and personalized compounded tirzepatide programs are available to eligible adults in Hawaii, along with micro-dose versions of each. A provider with Wasef Health, PC recommends the option that fits your health history and goals.
Yes. Micro-dose tirzepatide is one of Bodi Envi's programs, and Hawaii patients are assessed for it the same way as for the standard program. Whether it is prescribed is the decision of a licensed provider with Wasef Health, PC.
Your assessment goes to a licensed provider with Wasef Health, PC, who evaluates it and decides whether to prescribe. When a prescription is issued, VialsRx dispenses the medication and delivers it to your Hawaii address. From there you can message the care team about your treatment at any point.
Personalized compounded semaglutide and personalized compounded tirzepatide are not FDA-approved and are not equivalent to FDA-approved products.
The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.
Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
Treatment is not guaranteed. A licensed healthcare provider determines whether treatment is appropriate for each individual patient. Individual experiences and outcomes vary. If a patient is not qualified, a refund will be issued.
Bodi Envi is not a medical practice, pharmacy, or medication manufacturer. Brand names are trademarks of their respective owners.
Answer the health questions online and let a licensed provider decide whether personalized compounded tirzepatide fits. If it does, your medication is delivered to your Hawaii address. Treatment is not guaranteed, and Hawaii residents pay the same published price at every dose. If a patient is not qualified, a refund will be issued.